CONCENTRATIONS |
9 Months Ended |
---|---|
Sep. 30, 2021 | |
CONCENTRATIONS | |
NOTE 18 - CONCENTRATIONS |
NOTE 18 - CONCENTRATIONS
Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.
The Company's revenues earned from sale of products and services for the three months ended September 30, 2021 included 100% from one customer of the Company's total revenues.
The Company's revenues earned from sale of products and services for the nine months ended September 30, 2021 included 75% from one customer of the Company's total revenues. The Company’s revenues earned from sale of products and services for the three months ended September 30, 2020 included 30% and 68% (aggregate of 98%) from two customers of the Company’s total revenues.
The Company’s revenues earned from sale of products and services for the nine months ended September 30, 2020 included 26% and 60% (aggregate of 86%) from two customers of the Company’s total revenues.
At September 30, 2021, there was no balance of the Company's total accounts receivable, and one customer accounted for 100% of the Company's total accounts receivable with an amount of $500 at December 31, 2020. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|